A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
- Author
- KEUN SEOK LEE1 ; RO, Jungsil1 ; KYUNG HWAN SHIN1 ; KIM, Seok-Ki1 ; NAM, Byung-Ho1 ; EUN SOOK LEE1 ; KWON, Youngmee1 ; HYE SOO KWON1 ; KI WOOK CHUNG1 ; HAN SUNG KANG1 ; KIM, Eun A1 ; SEOK WON KIM1
[1] Research Institute and Hospital, National Cancer Center, 809 Madu-1-dong, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, Korea, Republic of - Source
Breast cancer research and treatment. 2008, Vol 109, Num 3, pp 481-489, 9 p ; ref : 28 ref
- CODEN
- BCTRD6
- ISSN
- 0167-6806
- Scientific domain
- Medical oncology; Obstetrics, gynecology, andrology; Pharmacology drugs
- Publisher
- Springer, Dordrecht
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- Breast cancer Capecitabine Clinical trial Docetaxel Phase III
- Keyword (fr)
- Anticancéreux Cancer du sein Capécitabine Chimiothérapie Cyclophosphamide Docétaxel Doxorubicine Essai clinique phase III Essai clinique Etude comparative Homme Primaire Randomisation Stade précoce Stade localement avancé Agent alkylant Anthracyclines Antimitotique Cancer DNA topoisomerase (ATP-hydrolysing) Dérivé de l'oxazaphosphinane Dérivé de la fluoropyrimidine Dérivé du taxane Enzyme Inhibiteur de la topoisomérase II Inhibiteur enzyme Isomerases Moutarde à l'azote Pathologie de la glande mammaire Pathologie du sein Pyrimidine nucléoside Traitement Tumeur maligne
- Keyword (en)
- Antineoplastic agent Breast cancer Capecitabine Chemotherapy Cyclophosphamide Docetaxel Doxorubicin Phase III trial Clinical trial Comparative study Human Primary Randomization Early stage Locally advanced stage Alkylating agent Anthracyclins Antimitotic Cancer DNA topoisomerase (ATP-hydrolysing) Oxazaphosphinane derivatives Fluoropyrimidine derivatives Taxane derivatives Enzyme Topoisomerase II inhibitor Enzyme inhibitor Isomerases Nitrogen mustard Mammary gland diseases Breast disease Pyrimidine nucleoside Treatment Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pecho Capecitabina Quimioterapia Ciclofosfamida Docetaxel Doxorubicina Ensayo clínico fase III Ensayo clínico Estudio comparativo Hombre Primario Aleatorización Estadio precoz Estadio localmente avanzado Agente alquilante Antraciclinas Antimitótico Cáncer DNA topoisomerase (ATP-hydrolysing) Oxazafosfinano derivado Fluoropirimidina derivado Taxane derivado Enzima Inhibidor topoisomerase II Inhibidor enzima Isomerases Mostaza al nitrógeno Glándula mamaria patología Seno patología Pirimidina nucleósido Tratamiento Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20370122
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s10549-007-9672-y 
https://dx.doi.org/10.1007/s10549-007-9672-y
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"481\";s:8:\"\u0000*\u0000epage\";s:3:\"489\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"KEUN SEOK LEE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"RO, Jungsil\";i:1;s:15:\"KYUNG HWAN SHIN\";i:2;s:12:\"KIM, Seok-Ki\";i:3;s:13:\"NAM, Byung-Ho\";i:4;s:12:\"EUN SOOK LEE\";i:5;s:14:\"KWON, Youngmee\";i:6;s:12:\"HYE SOO KWON\";i:7;s:13:\"KI WOOK CHUNG\";i:8;s:13:\"HAN SUNG KANG\";i:9;s:10:\"KIM, Eun A\";i:10;s:12:\"SEOK WON KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"481\";s:8:\"\u0000*\u0000epage\";s:3:\"489\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"KEUN SEOK LEE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"RO, Jungsil\";i:1;s:15:\"KYUNG HWAN SHIN\";i:2;s:12:\"KIM, Seok-Ki\";i:3;s:13:\"NAM, Byung-Ho\";i:4;s:12:\"EUN SOOK LEE\";i:5;s:14:\"KWON, Youngmee\";i:6;s:12:\"HYE SOO KWON\";i:7;s:13:\"KI WOOK CHUNG\";i:8;s:13:\"HAN SUNG KANG\";i:9;s:10:\"KIM, Eun A\";i:10;s:12:\"SEOK WON KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"481\";s:8:\"\u0000*\u0000epage\";s:3:\"489\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"KEUN SEOK LEE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"RO, Jungsil\";i:1;s:15:\"KYUNG HWAN SHIN\";i:2;s:12:\"KIM, Seok-Ki\";i:3;s:13:\"NAM, Byung-Ho\";i:4;s:12:\"EUN SOOK LEE\";i:5;s:14:\"KWON, Youngmee\";i:6;s:12:\"HYE SOO KWON\";i:7;s:13:\"KI WOOK CHUNG\";i:8;s:13:\"HAN SUNG KANG\";i:9;s:10:\"KIM, Eun A\";i:10;s:12:\"SEOK WON KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"481\";s:8:\"\u0000*\u0000epage\";s:3:\"489\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"KEUN SEOK LEE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"RO, Jungsil\";i:1;s:15:\"KYUNG HWAN SHIN\";i:2;s:12:\"KIM, Seok-Ki\";i:3;s:13:\"NAM, Byung-Ho\";i:4;s:12:\"EUN SOOK LEE\";i:5;s:14:\"KWON, Youngmee\";i:6;s:12:\"HYE SOO KWON\";i:7;s:13:\"KI WOOK CHUNG\";i:8;s:13:\"HAN SUNG KANG\";i:9;s:10:\"KIM, Eun A\";i:10;s:12:\"SEOK WON KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-007-9672-y\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"109\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"481\";s:8:\"\u0000*\u0000epage\";s:3:\"489\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"KEUN SEOK LEE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"RO, Jungsil\";i:1;s:15:\"KYUNG HWAN SHIN\";i:2;s:12:\"KIM, Seok-Ki\";i:3;s:13:\"NAM, Byung-Ho\";i:4;s:12:\"EUN SOOK LEE\";i:5;s:14:\"KWON, Youngmee\";i:6;s:12:\"HYE SOO KWON\";i:7;s:13:\"KI WOOK CHUNG\";i:8;s:13:\"HAN SUNG KANG\";i:9;s:10:\"KIM, Eun A\";i:10;s:12:\"SEOK WON KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:159:\"A randomized phase-III trial of docetaxel\/capecitabine versus doxorubicin\/cyclophosphamide as primary chemotherapy for patients with stage II\/III breast cancer\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
